{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:07Z","timestamp":1785414187107,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00535-015-1131-7","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T13:38:50Z","timestamp":1446212330000},"page":"597-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis"],"prefix":"10.1007","volume":"51","author":[{"given":"Akiko","family":"Hisamochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Arinaga-Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryukichi","family":"Kumashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Torimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","volume":"8","author":"BH Stricker","year":"1988","unstructured":"Stricker BH, Blok AP, Claas FH, et al. Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology. 1988;8:599\u2013606.","journal-title":"Hepatology"},{"key":"1131_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197110072851501","volume":"285","author":"TB Reynolds","year":"1971","unstructured":"Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971;285:813\u201320.","journal-title":"N Engl J Med"},{"key":"1131_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1572-0241.2000.t01-1-01809.x","volume":"95","author":"T Pohle","year":"2000","unstructured":"Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol. 2000;95:560\u20131.","journal-title":"Am J Gastroenterol"},{"key":"1131_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2796.2001.00848.x","volume":"250","author":"Z Punthakee","year":"2001","unstructured":"Punthakee Z, Scully LJ, Guindi MM, et al. Liver fibrosis attributed to lipid lowering medications: two cases. J Intern Med. 2001;250:249\u201354.","journal-title":"J Intern Med"},{"key":"1131_CR5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200308000-00014","volume":"15","author":"N Pelli","year":"2003","unstructured":"Pelli N, Setti M, Ceppa P, et al. Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol. 2003;15:921\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1131_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12328-013-0359-0","volume":"6","author":"A Hisamochi","year":"2013","unstructured":"Hisamochi A, Kage M, Arinaga T, et al. Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis. Clin J Gastroenterol. 2013;6:139\u201344.","journal-title":"Clin J Gastroenterol"},{"key":"1131_CR7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040\u20138.","journal-title":"Hepatology"},{"key":"1131_CR8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of International consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323\u201330.","journal-title":"J Clin Epidemiol"},{"key":"1131_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hepres.2005.05.007","volume":"32","author":"H Takikawa","year":"2005","unstructured":"Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res. 2005;32:250\u20131.","journal-title":"Hepatol Res"},{"key":"1131_CR10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"1131_CR11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0016-5085(93)90037-D","volume":"105","author":"J Ludwig","year":"1993","unstructured":"Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology. 1993;105:274\u20138.","journal-title":"Gastroenterology"},{"key":"1131_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"1131_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-8278(97)82329-X","volume":"26","author":"MA Robin","year":"1997","unstructured":"Robin MA, Le Roy M, Descatoire V, et al. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol. 1997;26:23\u201330.","journal-title":"J Hepatol"},{"key":"1131_CR14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510260438","volume":"26","author":"MP Manns","year":"1997","unstructured":"Manns MP, Obermayer-straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology. 1997;26:1054\u201366.","journal-title":"Hepatology"},{"key":"1131_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1054-3589(08)60175-1","volume":"30","author":"P Beaune","year":"1994","unstructured":"Beaune P, Pessayre D, Dansette P, et al. Autoantibodies against cytochromes P450: role in human disease. Adv Pharmacol. 1994;30:199\u2013245.","journal-title":"Adv Pharmacol"},{"key":"1131_CR16","first-page":"561","volume":"55","author":"JC Homberg","year":"1984","unstructured":"Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (LKM-2) in tienilic acid-induced hepatitis. Clin Exp Immunol. 1984;55:561\u201370.","journal-title":"Clin Exp Immunol"},{"key":"1131_CR17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.1840050504","volume":"5","author":"JC Homberg","year":"1985","unstructured":"Homberg JC, Abuaf N, Helmy-Khalil S, et al. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology. 1985;5:722\u20137.","journal-title":"Hepatology"},{"key":"1131_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","volume":"84","author":"PH Beaune","year":"1987","unstructured":"Beaune PH, Dansette PM, Mansuy D, et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA. 1987;84:551\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1131_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1432-1033.1993.tb17752.x","volume":"213","author":"MP Lopez Garcia","year":"1993","unstructured":"Lopez Garcia MP, Dansette PM, Valadon P, et al. Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur J Biochem. 1993;213:223\u201332.","journal-title":"Eur J Biochem"},{"key":"1131_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/tx00039a023","volume":"7","author":"S Lecoeur","year":"1994","unstructured":"Lecoeur S, Bonierbale E, Challine D, et al. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem Res Toxicol. 1994;7:434\u201342.","journal-title":"Chem Res Toxicol"},{"key":"1131_CR21","first-page":"1751","volume":"90","author":"J Nataf","year":"1986","unstructured":"Nataf J, Bernuau J, Larrey D, et al. A new anti-liver microsome antibody: a specific marker of dihydralazine-induced hepatitis. Gastroenterology. 1986;90:1751.","journal-title":"Gastroenterology"},{"key":"1131_CR22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI114660","volume":"85","author":"M Bourdi","year":"1990","unstructured":"Bourdi M, Larrey D, Nataf J, et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450 1A2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest. 1990;85:1967\u201373.","journal-title":"J Clin Invest"},{"key":"1131_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1872-034X.2008.00486.x","volume":"39","author":"H Takikawa","year":"2009","unstructured":"Takikawa H, Murata Y, Horiike N, et al. Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006. Hepatol Res. 2009;39:427\u201331.","journal-title":"Hepatol Res"},{"key":"1131_CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","volume":"13","author":"PT Donaldson","year":"1991","unstructured":"Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701\u20136.","journal-title":"Hepatology"},{"key":"1131_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2002-35705","volume":"22","author":"PT Donaldson","year":"2002","unstructured":"Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis. 2002;22:353\u201364.","journal-title":"Semin Liver Dis"},{"key":"1131_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000063890","volume":"205","author":"C Bachmeyer","year":"2002","unstructured":"Bachmeyer C, Candranel JF. Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors. Dermatology. 2002;205:185\u20136.","journal-title":"Dermatology"},{"key":"1131_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0961203303lu313cr","volume":"12","author":"IW Graziadei","year":"2003","unstructured":"Graziadei IW, Obermoser GE, Sepp NT, et al. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus. 2003;12:409\u201312.","journal-title":"Lupus"},{"key":"1131_CR28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","volume":"103","author":"T Seki","year":"1992","unstructured":"Seki T, Ota M, Furuta S, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology. 1992;103:1041\u20137.","journal-title":"Gastroenterology"},{"key":"1131_CR29","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.1840120609","volume":"12","author":"T Seki","year":"1990","unstructured":"Seki T, Kiyosawa K, Inoko H, et al. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology. 1990;12:1300\u20134.","journal-title":"Hepatology"},{"key":"1131_CR30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol. 1997;26:1207\u201312.","journal-title":"J Hepatol"},{"key":"1131_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","volume":"124","author":"IR Mackay","year":"1965","unstructured":"Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sc. 1965;124:767\u201380.","journal-title":"Ann NY Acad Sc"},{"key":"1131_CR32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","volume":"40","author":"Vamsee Alla","year":"2006","unstructured":"Alla Vamsee, Abraham Joseph, Siddiqui Junaid, et al. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol. 2006;40:757\u201361.","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1131-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-015-1131-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1131-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T21:23:18Z","timestamp":1653427398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-015-1131-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1007\/s00535-015-1131-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}